Selective CB2 receptor agonists. Part 2: Structure-activity relationship studies and optimization of proline-based compounds.
暂无分享，去创建一个
E. Hickey | M. Gemkow | A. Ceci | H. Romig | D. Thomson | Angela K Berry | A. Sauer | C. Albrecht | Lifen Wu | Doris Riether | N. Nagaraja | Raj Betageri | R. Zindell | M. Ermann | James E Jenkins | Someina Khor | Renee M. Zindell